- Home
- BGLC vs ATXG Comparison
BGLC vs ATXG Comparison
Compare BGLC & ATXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGLC
- ATXG
- Stock Information
- Founded
- BGLC 2017
- ATXG 2014
- Country
- BGLC Malaysia
- ATXG China
- Employees
- BGLC N/A
- ATXG N/A
- Industry
- BGLC Medical Specialities
- ATXG Professional Services
- Sector
- BGLC Health Care
- ATXG Consumer Discretionary
- Exchange
- BGLC Nasdaq
- ATXG Nasdaq
- Market Cap
- BGLC 5.8M
- ATXG 5.4M
- IPO Year
- BGLC N/A
- ATXG N/A
- Fundamental
- Price
- BGLC $2.88
- ATXG $0.70
- Analyst Decision
- BGLC
- ATXG
- Analyst Count
- BGLC 0
- ATXG 0
- Target Price
- BGLC N/A
- ATXG N/A
- AVG Volume (30 Days)
- BGLC 1.8M
- ATXG 13.7K
- Earning Date
- BGLC 04-15-2025
- ATXG 02-14-2025
- Dividend Yield
- BGLC N/A
- ATXG N/A
- EPS Growth
- BGLC N/A
- ATXG N/A
- EPS
- BGLC N/A
- ATXG N/A
- Revenue
- BGLC $9,510,646.00
- ATXG $4,549,310.00
- Revenue This Year
- BGLC N/A
- ATXG N/A
- Revenue Next Year
- BGLC N/A
- ATXG N/A
- P/E Ratio
- BGLC N/A
- ATXG N/A
- Revenue Growth
- BGLC N/A
- ATXG N/A
- 52 Week Low
- BGLC $2.01
- ATXG $0.49
- 52 Week High
- BGLC $8.40
- ATXG $1.18
- Technical
- Relative Strength Index (RSI)
- BGLC 51.78
- ATXG 48.24
- Support Level
- BGLC $2.47
- ATXG $0.60
- Resistance Level
- BGLC $2.99
- ATXG $0.70
- Average True Range (ATR)
- BGLC 0.49
- ATXG 0.08
- MACD
- BGLC 0.07
- ATXG 0.01
- Stochastic Oscillator
- BGLC 58.87
- ATXG 50.00
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.
About ATXG Addentax Group Corp.
Addentax Group Corp is an investment holding company. The company through its operating subsidiaries functions in the following segments; Garment manufacturing; Logistics services; Property management and subleasing. It generates maximum revenue from the Logistics services segment which provides logistics services including storage, transportation, warehousing, handling, packaging, and order processing. It also provides customs declaration and tax clearance services to its customers who export goods overseas. Geographically, the company derives all of its revenue from China.